+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
ID07495384

Study of CapsuleX and Cisplatin Treatment for Women with Platinum-Resistant Recurrent Ovarian Cancer

Led by The First Hospital of Jilin University · Updated on 2026-03-27

40

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the combination of CapsuleX and cisplatin for treating platinum-resistant recurrent ovarian cancer. This single-arm, open-label, prospective clinical trial aims to assess how well this combination works measured by objective response rate and its safety by monitoring adverse events in patients with this challenging form of ovarian cancer. The study is sponsored by The First Hospital of Jilin University. Participants will receive CapsuleX combined with cisplatin as the experimental treatment. The trial does not include a comparison group and is designed to observe the effects of this combination specifically in patients whose cancer has recurred and is resistant to platinum-based therapies. The treatment duration and dosing details are determined by the study protocol, focusing on this combination therapy. During the study, participants will undergo regular evaluations including tumor assessments according to RECIST 1.1 criteria to measure response, and safety monitoring for adverse events. The main outcome measured is the objective response rate over a five-year period. Participants will also provide tumor tissue samples when possible and complete follow-up procedures as required. The expected survival time for participants is at least six months, and organ function and overall health status will be closely monitored throughout the trial.

CONDITIONS

Brief Title

Efficacy and Safety of CapsuleX Combined With Cisplatin in Platinum-Resistant Recurrent Ovarian Cancer: A Single-Arm Prospective Clinical Study

Research Team

Z

Zhentong Wei Medic

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here